Bone sialoprotein (BSP), a bone matrix-enriched glycoprotein containing the Arg-Gly-Asp (RGD) motif and endowed with cell binding properties, was localized in osteoblasts and early bone matrix of developing rat bone at the ultrastructural level. Preliminary light microscopic observations indicated that intracellular labelling was restricted to a paranuclear dot corresponding to the "negative Golgi image'' of classical histology. The same pattern was observed whether antisera against the fully glycosylated protein or a peptide antiserum to a stretch of amino acids in human BSP sequence were employed. At the EM level, we obtained labeling over the Golgi area of osteoblasts but not over the rER. The labeling was concentrated over distensions of the u a~s Golgi and over pro-secretory granules. In the matrix, BSP was dis-tributed in a non-random manner. The label was concentrated over spherical aggregates of finely fibrillar material corresponding to the sites of early mineral deposition (socalled "mineralization nodules"). Such BSPpositive foci were seen both close to and away from the cell surface. The predominant association of BSP with Golgi and post-Golgi secretory structures and its absence from rER, as well as the reproduability of the same pattern of localization with different antisera, might indicate a slow transit of the protein through the Golgi, not necessarily associated with protein glycosylauon. ( J Histochem Cyrochem 41:193-203, 1993) 
Introduction
Bone sialoprotein (BSP) is a highly glycosylated protein of MI 70,000 (11, 12, 13, 19) which accounts for about 10% of the total noncollagenous protein of newly mineralized bone matrix, with interspecies and age-dependent variations. BSP expression is highly restricted to skeletal tissues, although not entirely specific for bone. The amino acid sequences of the rat (25) and human (12) protein have been deduced from cDNA clones and shown to contain the integrin-recognition motif Arg-Gly-Asp (RGD) (28) . In keeping with the occurrence of the RGD motif in its sequence, BSP promotes cell attachment and spreading in vitro (14, 15, 30) . Potential physiological roles for BSP, probably related to BSP-integrin interaction, may occur in both elementary processes of bone growth and remodeling, i.e., formation and resorption. Osteoblasts are the main source of BSP (3, 9, 12) , but some mRNA can also be detected in osteoclasts (3) . Both osteoblasts (14,15) and osteoclasts (24) attach and spread on BSP in vitro; osteoclasts express appropriate integrins to recognize BSP (3233) and exhibit physiological responses when exposed to BSP (24) . Nevertheless, the mechanism by which the cell binding property of BSP translates into defined roles in bone physiology remains unclear. Many heterogeneous phenomena (spreading of quiescent bone-lining cells onto bone surfaces, cell adhesion to matrix and release from adhesion, cell proliferation and migration, to mention a few) may all depend on integrin-ligand interaction. Attempts to address this issue would clearly benefit from a more detailed understanding of the specific cellular events associated with BSP production in vivo during both bone formation and resorption, including its distribution within the matrix. This article reports the ultrastructural localization of BSP in OSteoblasts and bone matrix of developing rat bone.
Materials and Methods
Antisera to BSP. Three different rabbit antisera were used for preliminary immunolocalization of BSP at the light microscopy level. LF 6 (11.12) 193 was raised against BSP purified from human developing bone. LF 87 was raised against highly purified BSP produced by UMR-106-BSP, a rat osteosatcoma cell line (23). LF 83 was generated using a synthetic peptide corresponding to a stretch of amino acids (277-2!94; TESEQGEPRGDQYRWED) in the BSP sequence and including the RGD-containing region, conjugated to the hemocyanin of Limuhspolyphemus (LPH). All three antisera recognized rat BSP in dot-blot and Western blot assays. All three antisera were used for light microscopic localization, whereas only LF 6 was used for EM immunocytochemistry.
Light Micmampic Immunocytochemistry of BSP. Bone tissue samples (mandible, ribs, femur) from rat fetuses at Days 15 and 18 of gestation were fxed for 2-8 hr in 4% formaldehyde (freshly made from paraformaldehyde) in 0.1 M phosphate buffer, pH 7.2, and embedded undemineralized in paraffin. Deparaffinized sections were exposed to 0.3% hydrogen peroxide for 15 min, then to undiluted normal goat serum for 20 min at room temperature. Anti-BSP antisera [diluted 1:100 in PBS, 0.1% bovine serum albumin, fraction V (BSA)] were applied for 2 hr at room temperature. Peroxidase-labeled goat anti-rabbit IgG (Dako; Santa Barbara, CA) (diluted 1:50 in PBS, 0.1% BSA) was used as a second antibody and was applied for 1 hr at room temperature. Peroxidase was revealed by the DAB reaction (16). Controls included omission of the first antiserum, replacement ofthe first antiserum with normal rabbit serum, and use of antisera pre-absorbed with human BSP (3).
Lowiayl K4M
Embedding. Tissue samples smaller than 0.5 mm3 were dehydrated in ethanol at low temperature according to the following schedule: 30% ethanol, 30 min at O"C, 50% ethanol, 50 min at -2O'C; 70% ethanol, 60 min at -35'C 95% ethanol, 60 min at -35'C 100% ethanol, twice for 60 min at -35'C. Lowicryl K4M infiltration and embedding solutions were prepared according to the manufilcturer's specifications. Dehydrated specimens were infiltrated according to the following schedule: LowicryUethanol 1:1, 60 min at -35'C; Lowicryl/ethanol 25, 60 min at -35'C Luwicryl, overnight at -35'C. Specimenswerederred tohicryl embedding solution in pre-cooled Beem capsules. Polymerization was induced by w irradiation at -35'C overnight, followed by 2 days of w irradiation at room temperature. Semi-thin sections stained with methylene blue were used to select relevant fields (Osteoblasts and adjacent bone matrix). Thin sections from w-polymerized blocks were mounted on nickel grids and used for immunogold localization of BSP. Some sections were grid-demineralized by flotation on 1% formic acid for 5 min.
Araldite Embedding. Additional specimens were fixed with either Os04 (2% in 0.1 M phosphate buffer, pH 7.2). or 4% formaldehyde, followed by post-fixation with 1% os04 in 0.1 M phosphate buffer, pH 7.2, routinely ethanol-dehydrated, and embedded in an epoxy resin (Araldite; Fluka, Buchs, Switzerland). Undemineralized and grid-demineralized thin sections from Araldite blocks were "stained" with Ur/Pb and used for assessment of morphology and comparison with Lowicryl sections.
EM Immunocytochemistry of BSR Thin sections cut from h i c r y l K4M
blocks and mounted on nickel grids were exposed to undiluted normal goat serum for 1 hr at room temperature, then incubated overnight at 4°C on drops of BSP antiserum (LF 6) diluted 1:lO in PBS, 0.1% BSA. After washing in PBS (four times for 15 min), the grids were floated for 30 min at room temperature on drops of colloidal gold-labeled (particle size 10 nm) goat anti-rabbit IgG (BioCcll; Cardiff, UK), diluted 1:50 in PBS, 0.1% BSA.
Controls included omission of the BSP antiserum, its replacement with nor-mal rabbit serum, and the use of similar dilutions of rabbit antisera of unrelated specificity.
Results
In osteoblasts, immunostaining at the light microscopic level was seen as a single large paranuclear dot ( Figure 1 ) the same size, shape, and location as the "negative Golgi image" of classical histology (10,18). The same pattem of intracellular immunolabeling was observed with each of the three antisera to BSP used. Of these, two were directed against the fully glycosylated protein, whereas the third was generated against a synthetic peptide corresponding to amino acids 277-294 in the human BSP sequence. Figure 2 shows the size, position, and structure of osteoblast Golgi area as seen in Os04-fixed, epoxy resin-embedded material. The interpretation ofthe paranuclear "dot" of immunostaining seen in light microscopy as related to the Golgi area is clear when the immunolabeling and EM images are directly compared. Figure 3 shows the general pattem of EM localization of BSP in an osteoblast and adjacent subcellular developing matrix, as seen in a Lowicryl thin section immunolabeled with antiserum LF 6.
The label was essentially absent over the rER (where on occasion few gold particles, not above background, were seen) and was concentrated over a broad Golgi zone, confirming the pattem observed in light microscopy. There was strong labeling of newly deposited matrix, which contrasted with the absence of any label in the intercellular space.
Most of the sectional area of the osteoblast Golgi is taken up by large membrane-bound vacuoles (1, 29) which form at the trans face of the Golgi stacks (31) . The morphology of such vacuoles as seen in Os04-fixed or formaldehyde-fixed, Os04-post-fixed, epoxy-embedded specimens is shown in Figure 2B Elongated structures located near the osteoblast surface, consistent with pro-secretory granules, were also strongly labeled. Minor labeling was seen in occasional Golgi stacks. Transport vesicles and coated vesicles, well apparent in the Golgi area, were never labeled.
Exuacellular BSP was localized over discrete aggregates of moderately electron-dense material with a fibrillar intemal texture. These BSP-positive aggregates were seen both close to and away from cell surfaces ( Figure 6 ). Thin filaments projecting from pericellular aggregates of BSP-positive material were sometimes seen in direct contact or within less than 10 nm from the osteoblast surface. The BSPlabeled foci consistently appeared devoid of mineral in Lowicryl sections, whether these were grid-demineralized or not. Clear-cut evidence of early mineral aggregates in newly deposited bone matrix (so-called mineralization nodules) (1,2,6,7) was lacking altogether in Lowicryl sections, even when these sections were not 
!
(intentionally) grid-demineralized by exposure to an acid solution. However, the identity of the BSP-positive structures with foci of early mineral deposition was apparent when their size, distribution, shape, and overall morphology were compared with mineralization nodules as seen in standard EM images of osmicated, undemineralized, epoxy-embedded mineralizing bone (Figure 7) . No differences among different samples were observed. No intraor extracellular labeling was seen in controls.
Discussion
The paranuclear dot of labeling seen in light microscopic immunolocalization of BSP in this study and a previous one . (20,21) , however, reported a similar observation with an antiserum to rat osteopontin, a second, unrelated but RGDcontaining sialoprotein in the bone matrix. This peculiar pattern of labeling coincides with the "negative Golgi image" described long ago by Heller et al. (18) and also mentioned by Fell as early as 1925 (10). This "image" appears in routinely stained sections as a large paranuclear vacuole which stands out clearly against the background of the basophilic cytoplasm of osteoblasts. Our EM immunolocalization data directly explain the light microscopic pattern of labeling observed with antisera to BSP. In Lowicryl thin . , sections the label is absent over the rER and concentrates over large vacuoles within the Golgi area. When compared with conventional EM pictures of osteoblasts, the BSP-positive vacuoles are easily identified as the distensions that form at the trans face of each Golgi stack. Such distensions, described as "spherical" and "cylindrical" in earlier reports on osteoblast ultrastructure (31), have long been known to account for the largest proportion of the total Golgi area in osteoblasts (1) . On the basis of their location, morphology, and immunoreactivity for pro-collagen Type I. Wright and Leblond (31) interpreted them as the precursors of pro-secretory granules. If interpreted in the light of current models of the Golgi complex, these structures could thus be regarded as the osteoblast tranJ-Golgi network (EN) (17) .
Several explanations for the specific labeling of osteoblast Golgi structures can be considered. Detection of BSP in the Golgi but not in the rER might reflect its glycosylation in the Golgi. Given follow. However, localization of BSP produces a Golgi-like pattern even when an antibody directed against a stretch of amino acids including the the RGD site is substituted for antisera recognizing the secreted, fully glycosylated protein. Unless the relevant amino acid stretch is made more accessible to the "peptide" antiserum by a glycosylation-related change in protein folding, the labeling pattern would then simply and directly reflect varied amounts of antigen in different segments of the biosynthetic and secretory pathway. This would indicate that BSP is concentrated in the Golgi, and reaches the detection threshold as it enters the distensions emerging from the trans-Golgi face.
Proteins destined for secretion, insertion into the plasma membrane, or packaging into lysosomes are specifically sorted at the level of the hans -Golgi network (17,26,27) . In a number of cell types, concentration of secreted proteins in the Golgi and tnznr-Golgi network reflects signal-mediated retention and sorting of proteins destined for regulated secretion, as opposed to rapid bulk flow of pro-.
. Figure 6 . EM localization of BSP in newly deposited bone matrix. Lowicryl thin sections immunolabeled with LF 6. The label has a discrete, patchy distribution and concentrates over roundish structures with an internal fibrillar pattern, which are seen both close to (arrow) and away from (double arrow) the osteoblast surface. Note the close vicinity, if not the direct contact, of the thread-like peripheral projections of BSPlabeled material with the cell surface. Bar = 0.06 pm.
teins destined for constitutive secretion. However, secretory pathways operating in connective tissue and bone cells have not yet been e hcidated. Whether specific secreted proteins can be separately sorted in the osteoblast Golgi, whether osteoblast secretion is entirely or in part regulated, and how the final steps of packaging, transport, and extrusion of secretion occur are poorly understood. It also remains to be determined whether non-collagenous proteins and collagen share the same secretory pathway or whether specific pathways are present. Intracellular collagen Type I has been localized to the rER, Golgi stacks, and Golgi distensions and pro-secretory granules (31). We have observed BSP localization over Golgi distensions and pro-secretory granules that morphologically resemble those immunoreactive for collagen (31) . However, double immunolabeling experiments at the EM level are needed to conclusively determine whether collagen and BSP co-localize in the same individual post-Golgi distensions and granules or may appear in separate but morphologically similar structures. Once secreted, BSP appears to distribute in the matrix in multiple discrete foci. We interpreted the multiple discrete foci of BSP labeling in the matrix as coincident with the so-called mineralization nodules, widely known as the sites of earliest mineral deposition in bone (1,2,6,7) . These structures closely resemble our BSP-positive foci in size, shape, pattem of distribution, and overall morphology. The resemblance is more directly appreciated when decalcified mineralization nodules as seen in grid-demineralized sections are considered (7). The lack of mineral at the level of our BSP-positive structures most likely reflects artifactual demineralization of Lowicryl sections while floating on water in the knife trough. This effect is commonly observed in Lowicryl sections of developing bone, probably as a result of the high hydrophilicity of the resin.
A close association of individual non-collagenous proteins of bone matrix with sites of earliest mineral deposition has long been pursued as evidence for a physiological role of each protein in mineral nucleation. For any protein to qualdy as a candidate for such a role, it should be localized in the matrix with exactly the pattern we observed for BSP. Osteopontin has also been recently reported to exhibit a comparable pattern of EM localization (22) . We maintain that no mechanistic view can be construed from static localization images, which are open to several alternate explanations. The pattern of BSP localization that we observed may represent either mineral nucleation or adsorption of a highly charged protein onto forming mineral. In the first instance, the focal distribution of BSP would imply that it is focally deposited, i.e., individual packets or "quanta" of BSP-enriched secretory product are discretely deposited and provide specific microenvironments for mineral formation. In the second instance, one must postulate that the protein is deposited randomly, and secondarily relocates onto sites of independent mineral formation, thus producing the discrete pattern of distribution observed. In this case, mineral formation would be bringing about a remarkable change in the spatial pattern of distribution of a cell binding protein within the matrix. This would make mineralization itself the initiator of a change in cell-matrix interactions.
We observed BSP-positive structures as close to cell surfaces as 10 nm or less, a distance consistent with direct interactions between the protein and cell surfaces. Furthermore, cell surfaces frequently surrounded the clusters of BSP-labeled material over three quarters of their two-dimensional profile, a type of image that might suggest either the opening of a secretory granule to the cell surface or an influence of BSP in molding the profile of the apical surface of bone cells. Mineralization is known to occur at a greater distance from cell surfaces. However, EM documentation of close contacts between mineralization nodules and osteoblast surfaces is not uncommon, particularly in the rapidly mineralizing embryonic bone, which may lack a distinct mineralization front as commonly seen in postnatal bone (1). Whether our findings reflect a potential functional link between cell-matrix adhesion and mineralization, per-haps mediated by BSP, cannot be conclusively stated. However, it might be contemplated as a potential issue for further studies.
In conclusion, ultrastructural locahzation data of BSP in developing bone indicate that BSP may undergo specific concentration in the Golgi and post-Golgi secretory structures, and demonstrate a specific pattern of BSP distribution in the matrix. This pattern can be consistent with BSP contributing to generate specific microenvironments for mineral deposition. At the level of some of these foci cell-matrix adhesion may also occur.
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